Condition: Gallstone Disease · Gallbladder Malignant Neoplasm · Sponsor: Centre Paul Strauss
We have observed that the serum levels of certain metabolites differ between Chilean patients with gallbladder cancer and those with gallstone disease. Based on these discovery results, we selected ten candidate metabolites based on the smallest p-values among metabolites exhibiting a fold-change greater than 1.5. The aim of the present study is to validate these ten differential metabolite levels in an independent cohort of Chilean patients with gallbladder cancer and gallstone disease, and to assess the transferability of these findings to other patient populations.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Complejo Hospitalario Viedma | Cochabamba, Bolivia | — |
| Hospital del Norte | Cochabamba, Bolivia | — |
| Hospital Obrero No. 2 (Caja Nacional del Seguro Social) | Cochabamba, Bolivia | — |
| Instituto Gastroenterológico | Cochabamba, Bolivia | — |
| Instituto Oncológico Nacional | Cochabamba, Bolivia | — |
| Hospital Clínico de Magallanes | Arica, Chile | — |
| Hospital Regional de Arica | Arica, Chile | — |
| Hospital Regional de Concepción, | Concepción, Chile | — |
| Hospital De Puerto Montt | Port Montt, Chile | — |
| Hospital Regional de Rancagua | Rancagua, Chile | — |
| Clínica Alemana de Santiago | Santiago, Chile | — |
| Fundación Arturo López Perez (FALP) | Santiago, Chile | — |
+ 21 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.